ENSEM Therapeutics

ENSEM Therapeutics

  • Founded: 2021
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: Undisclosed
  • Product link: https://ensemtx.com/
  • Funding: $67M A Apr 2022
  • Investors: GGV Capital, Pavilion Capital, Cenova Capital, Mitsui & Co. Global Investment, Inc., CBC Group



job board

Short description:

Characterizing rare conformational states in drug targets

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

ENSEM Therapeutics is developing precision drugs for oncology targets to address unmet clinical needs. To address oncology, non-obvious binding pockets on difficult-to-drug targets need to be found. Through the use of computational and AI deep learning methodologies combined with advanced experimental techniques, ENSEM has created their Kinetic Ensemble ® platform that identifies cryptic binding pockets and accelerates structure-based drug design. The platform uses data from multiple sources including clinical, imaging, molecular and multi-omics. ENSEM can use their approach to develop innovative small molecule precision medicines for oncology with the potential of targeting other diseases and genetic disorders.


ENSEM Therapeutics
Senior Director, Strategic Business Development
Waltham, MA|53 days ago
ENSEM Therapeutics
VP and Head of Clinical Development
Waltham, MA|53 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com